Your browser doesn't support javascript.
loading
Severe hepatitis E infection in pregnancy: a case report.
Jha, Kritika; Tandukar, Alina; Aryal, Roshan; Shrestha, Prezma; Bajracharya, Sunita; Bista, Kesang D.
Affiliation
  • Jha K; Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital.
  • Tandukar A; Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital.
  • Aryal R; Maharajgunj Medical Campus, Institute of Medicine, Maharajgunj, Nepal.
  • Shrestha P; Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital.
  • Bajracharya S; Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital.
  • Bista KD; Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital.
Ann Med Surg (Lond) ; 85(4): 1213-1215, 2023 Apr.
Article de En | MEDLINE | ID: mdl-37113858
ABSTRACT
Hepatitis E virus causes self limiting hepatitis most of the times but, during pregnancy it can lead to severe hepatitis along with various complications thereby increasing the mortality. Case presentation A 27-year-old woman gravida two, para one at 38 weeks and 6 days of gestation presented with multiple episodes of nonbilious vomiting, severe dehydration, and later developed right upper quadrant abdominal pain. The patient had a positive serological test for the hepatitis E virus, and liver enzymes were severely elevated. Under supportive treatment she delivered a healthy baby, and her liver enzymes returned to normal levels after 2 weeks of delivery. Clinical

discussion:

Although the hepatitis E virus usually causes self-limiting hepatitis, it can quickly progress to severe hepatitis, liver failure, and even death during pregnancy. Immunological change with a Th2 biased response and increased hormonal levels during pregnancy could possibly facilitate the development of severe liver damage. No particular drug has been approved for the treatment of hepatitis E viral infection in pregnant women, and the commonly used drugs are contraindicated due to the risk of teratogenicity. Supportive therapy and intensive monitoring are the core management techniques for hepatitis E virus infection in pregnant women.

Conclusion:

Due to the high mortality risk, pregnant women should try to avoid possible exposure to the hepatitis E virus, but once infected, symptomatic therapy is the mainstay.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Ann Med Surg (Lond) Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Ann Med Surg (Lond) Année: 2023 Type de document: Article